Benefits of preserving residual renal function in peritoneal dialysis

Slides:

Advertisements

Similar presentations

Home care assistance and the utilization of peritoneal dialysis

Advertisements

A skeptical view of assisted home peritoneal dialysis

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

A.M. Thompson, T.G. Pickering Kidney International

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Beta blockers in the management of chronic kidney disease

Volume 70, Pages S138-S145 (November 2006)

Anemia management in chronic kidney disease

End-stage renal disease in developing countries

Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis James F. Medcalf, Kevin P.G.

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Impact of new dialysis solutions on peritonitis rates

Volume 72, Issue 8, Pages (October 2007)

Volume 64, Pages S3-S12 (December 2003)

Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy G. Viglino, L. Neri, S. Barbieri Kidney.

Progression of renal failure and hypertensive nephrosclerosis

John P. Middleton, Patrick H. Pun Kidney International

Inflammation and wasting in chronic kidney disease: Partners in crime

Francesco Paolo Schena Kidney International

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Volume 73, Issue 4, Pages (February 2008)

Volume 70, Pages S21-S25 (December 2006)

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

Malnutrition and inflammation in peritoneal dialysis patients

Volume 71, Issue 2, Pages (January 2007)

Volume 72, Issue 9, Pages (November 2007)

French peritoneal dialysis registry (RDPLF): Outline and main results

Anemia as a risk factor for chronic kidney disease

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 73, Pages S81-S86 (April 2008)

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Volume 73, Pages S5-S17 (April 2008)

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function S.L.S. Fan, T. Pile, S. Punzalan, M.J.

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

Counteracting progression of renal disease: A look into the future

Lynda Anne Szczech, Ira L. Lazar Kidney International

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 73, Pages S72-S75 (April 2008)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

A skeptical view of assisted home peritoneal dialysis

Homocysteine, renal function, and risk of cardiovascular disease

Volume 70, Issue 3, Pages (August 2006)

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Renal replacement therapy in Latin America

Volume 70, Issue 5, Pages (September 2006)

Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton

Volume 75, Issue 7, Pages (April 2009)

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Volume 57, Pages S44-S48 (April 2000)

Presentation transcript:

Benefits of preserving residual renal function in peritoneal dialysis B. Marrón, C. Remón, M. Pérez-Fontán, P. Quirós, A. Ortíz Kidney International Volume 73, Pages S42-S51 (April 2008) DOI: 10.1038/sj.ki.5002600 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Patient survival and technique success curves, according to RRF from the Andalusian Registry. Technique success refers to the probability of being both alive and on PD therapy. Kidney International 2008 73, S42-S51DOI: (10.1038/sj.ki.5002600) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Loss of RRF contributes to inflammation, anemia, malnutrition, LVH, volume overload, hypertension and cardiovascular disease in PD patients, and interacts with them to increase morbidity and mortality. The decrease or absence of RRF itself is an independent adverse risk factor. Kidney International 2008 73, S42-S51DOI: (10.1038/sj.ki.5002600) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Factors associated with risk of loss of RRF. Adapted from Moist et al.5 Kidney International 2008 73, S42-S51DOI: (10.1038/sj.ki.5002600) Copyright © 2008 International Society of Nephrology Terms and Conditions